REYKJAVIK, Iceland & MORRISTOWN, N.J.--(BUSINESS WIRE)--Actavis South Atlantic (ASA), a United States division of the international generic pharmaceutical company Actavis, has opened new analytical and R&D laboratories to expand the Company’s research and development efforts for controlled release (CR) and other technically difficult generic pharmaceutical products.
